USD 10.21
(-2.3%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -173.39 Million USD | -22.44% |
2022 | -121.1 Million USD | -11.23% |
2021 | -108.87 Million USD | -136.23% |
2020 | -46.08 Million USD | -19.19% |
2019 | -38.66 Million USD | -72.31% |
2018 | -22.44 Million USD | -149.25% |
2017 | -9 Million USD | 41.45% |
2016 | -15.37 Million USD | 91.08% |
2015 | -172.43 Million USD | -9451.36% |
2014 | 1.84 Million USD | 102.51% |
2013 | -73.43 Million USD | -646.5% |
2012 | -9.83 Million USD | 59.88% |
2011 | -24.51 Million USD | -107.96% |
2010 | -11.78 Million USD | -23.35% |
2009 | -9.55 Million USD | 65.63% |
2008 | -27.8 Million USD | -41.25% |
2007 | -19.68 Million USD | 10.98% |
2006 | -22.11 Million USD | -47.0% |
2005 | -15.04 Million USD | -8560.46% |
2004 | 177.81 Thousand USD | -98.37% |
2003 | 10.89 Million USD | 1464.76% |
2002 | -798 Thousand USD | -387.87% |
2001 | 277.21 Thousand USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -38.24 Million USD | -9.15% |
2024 Q3 | -88.44 Million USD | 7.26% |
2024 Q2 | -33.07 Million USD | 13.5% |
2023 FY | -148.27 Million USD | -22.44% |
2023 Q2 | -49.85 Million USD | -34.83% |
2023 Q3 | -38.35 Million USD | 23.07% |
2023 Q4 | -35.03 Million USD | 8.66% |
2023 Q1 | -36.98 Million USD | -33.95% |
2022 Q2 | -29.96 Million USD | 6.96% |
2022 Q4 | -27.6 Million USD | 21.06% |
2022 FY | -121.1 Million USD | -11.23% |
2022 Q1 | -32.2 Million USD | 15.55% |
2022 Q3 | -34.97 Million USD | -16.7% |
2021 Q2 | -35.75 Million USD | -87.71% |
2021 Q4 | -38.13 Million USD | -8.59% |
2021 FY | -108.87 Million USD | -136.23% |
2021 Q1 | -19.04 Million USD | -11.8% |
2021 Q3 | -35.12 Million USD | 1.76% |
2020 Q2 | -11.15 Million USD | 37.34% |
2020 Q3 | -12.86 Million USD | -15.26% |
2020 FY | -46.08 Million USD | -19.19% |
2020 Q4 | -17.03 Million USD | -32.46% |
2020 Q1 | -17.8 Million USD | -22.82% |
2019 Q3 | -11.59 Million USD | -11.36% |
2019 Q2 | -10.41 Million USD | 3.27% |
2019 Q1 | -10.76 Million USD | -39.91% |
2019 FY | -38.66 Million USD | -72.31% |
2019 Q4 | -14.49 Million USD | -25.02% |
2018 Q3 | -7.53 Million USD | -15.1% |
2018 Q4 | -7.69 Million USD | -2.15% |
2018 FY | -22.44 Million USD | -149.25% |
2018 Q1 | -667 Thousand USD | 81.51% |
2018 Q2 | -6.54 Million USD | -881.26% |
2017 Q4 | -3.6 Million USD | -186.12% |
2017 FY | -9 Million USD | 41.45% |
2017 Q3 | -1.26 Million USD | -71.56% |
2017 Q2 | -735 Thousand USD | 78.38% |
2017 Q1 | -3.39 Million USD | 51.88% |
2016 FY | -15.37 Million USD | 91.08% |
2016 Q1 | -3.73 Million USD | 35.6% |
2016 Q4 | -7.06 Million USD | -55.29% |
2016 Q3 | -4.54 Million USD | -290.81% |
2016 Q2 | -1.16 Million USD | 68.87% |
2015 Q1 | 1.14 Million USD | -61.59% |
2015 Q4 | -5.8 Million USD | 96.48% |
2015 FY | -172.43 Million USD | -9451.36% |
2015 Q2 | -2.82 Million USD | -347.55% |
2015 Q3 | -164.94 Million USD | -5734.74% |
2014 Q3 | 1.73 Million USD | -5.92% |
2014 FY | 1.84 Million USD | 102.51% |
2014 Q4 | 2.97 Million USD | 71.65% |
2014 Q1 | -4.7 Million USD | 91.6% |
2014 Q2 | 1.84 Million USD | 139.15% |
2013 Q4 | -56 Million USD | -325.09% |
2013 FY | -73.43 Million USD | -646.5% |
2013 Q3 | -13.17 Million USD | -354.43% |
2013 Q1 | -1.35 Million USD | 65.95% |
2013 Q2 | -2.89 Million USD | -113.48% |
2012 Q4 | -3.98 Million USD | -102.03% |
2012 Q1 | -126 Thousand USD | 99.24% |
2012 Q3 | -1.97 Million USD | 47.37% |
2012 FY | -9.83 Million USD | 59.88% |
2012 Q2 | -3.75 Million USD | -2876.98% |
2011 Q3 | -2.36 Million USD | 28.51% |
2011 FY | -24.51 Million USD | -107.96% |
2011 Q4 | -16.48 Million USD | -598.05% |
2011 Q2 | -3.3 Million USD | -39.88% |
2011 Q1 | -2.36 Million USD | -39.27% |
2010 Q1 | -3.63 Million USD | -1017.23% |
2010 FY | -11.78 Million USD | -23.35% |
2010 Q2 | -3.05 Million USD | 15.81% |
2010 Q4 | -1.69 Million USD | 51.19% |
2010 Q3 | -3.47 Million USD | -13.67% |
2009 Q4 | -325 Thousand USD | 50.53% |
2009 Q2 | -5.45 Million USD | -74.49% |
2009 Q1 | -3.12 Million USD | 25.1% |
2009 FY | -9.55 Million USD | 65.63% |
2009 Q3 | -657 Thousand USD | 87.95% |
2008 Q2 | -3.31 Million USD | 79.07% |
2008 FY | -27.8 Million USD | -41.25% |
2008 Q4 | -4.17 Million USD | 6.37% |
2008 Q1 | -15.86 Million USD | -42.17% |
2008 Q3 | -4.45 Million USD | -34.23% |
2007 FY | -19.68 Million USD | 10.98% |
2007 Q2 | -550 Thousand USD | 78.94% |
2007 Q3 | -5.36 Million USD | -876.0% |
2007 Q4 | -11.15 Million USD | -107.82% |
2007 Q1 | -2.61 Million USD | 72.75% |
2006 FY | -22.11 Million USD | -47.0% |
2006 Q4 | -9.58 Million USD | -70.87% |
2006 Q1 | -3.11 Million USD | 93.17% |
2006 Q2 | -3.81 Million USD | -22.5% |
2006 Q3 | -5.6 Million USD | -47.22% |
2005 Q2 | 11.8 Million USD | 71.1% |
2005 Q4 | -45.56 Million USD | -485.85% |
2005 Q1 | 6.9 Million USD | 152.33% |
2005 Q3 | 11.8 Million USD | 0.0% |
2005 FY | -15.04 Million USD | -8560.46% |
2004 Q3 | 4.45 Million USD | 0.0% |
2004 Q1 | 4.45 Million USD | 0.0% |
2004 Q2 | 4.45 Million USD | 0.0% |
2004 Q4 | -13.18 Million USD | -396.01% |
2004 FY | 177.81 Thousand USD | -98.37% |
2003 FY | 10.89 Million USD | 1464.76% |
2002 FY | -798 Thousand USD | -387.87% |
2001 FY | 277.21 Thousand USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Acutus Medical, Inc. | -14.36 Million USD | -1107.402% |
Cerus Corporation | -30.05 Million USD | -476.964% |
OrthoPediatrics Corp. | -25.76 Million USD | -572.96% |
PetVivo Holdings, Inc. | -10.62 Million USD | -1532.515% |
Talis Biomedical Corporation | -66.81 Million USD | -159.515% |
Vivos Therapeutics, Inc. | -17.29 Million USD | -902.515% |
Inogen, Inc. | -109.38 Million USD | -58.517% |
Spectral AI, Inc. | -12.98 Million USD | -1235.451% |
Nano-X Imaging Ltd. | -62.58 Million USD | -177.037% |
CVRx, Inc. | -43.1 Million USD | -302.281% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -4814.824% |
Helius Medical Technologies, Inc. | -12.42 Million USD | -1295.196% |
Orthofix Medical Inc. | -139.11 Million USD | -24.646% |
Venus Concept Inc. | -28.3 Million USD | -512.508% |
Accelerate Diagnostics, Inc. | -54.02 Million USD | -220.935% |
Bioventus Inc. | -81.72 Million USD | -112.169% |
BrainsWay Ltd. | -4.92 Million USD | -3419.282% |
Envoy Medical, Inc. | -18.37 Million USD | -843.852% |
electroCore, Inc. | -18.8 Million USD | -822.069% |
IceCure Medical Ltd | -15.57 Million USD | -1013.219% |
Lucid Diagnostics Inc. | -48.48 Million USD | -257.648% |
Monogram Orthopaedics, Inc. | -17.26 Million USD | -904.139% |
MaxCyte, Inc. | -48.29 Million USD | -259.003% |
NeuroOne Medical Technologies Corporation | -11.95 Million USD | -1350.367% |
Nexalin Technology, Inc. | -5.69 Million USD | -2943.996% |
PAVmed Inc | -68.79 Million USD | -152.046% |
Rapid Micro Biosystems, Inc. | -56.56 Million USD | -206.552% |
RxSight, Inc. | -50.08 Million USD | -246.201% |
Sight Sciences, Inc. | -57.27 Million USD | -202.746% |
SI-BONE, Inc. | -46.93 Million USD | -269.468% |
TELA Bio, Inc. | -44.07 Million USD | -293.409% |
TriSalus Life Sciences, Inc. | -54.15 Million USD | -220.212% |
Treace Medical Concepts, Inc. | -51.42 Million USD | -237.161% |
LivaNova PLC | -68.49 Million USD | -153.139% |
908 Devices Inc. | -42.75 Million USD | -305.526% |
Nemaura Medical Inc. | -9.59 Million USD | -1707.095% |
NeuroPace, Inc. | -27.17 Million USD | -538.092% |
LENSAR, Inc. | -12.22 Million USD | -1317.9% |
Apyx Medical Corporation | -17.25 Million USD | -904.664% |
Cutera, Inc. | -156.23 Million USD | -10.987% |
STRATA Skin Sciences, Inc. | -8.6 Million USD | -1915.284% |
BioSig Technologies, Inc. | -28.51 Million USD | -508.147% |
Anika Therapeutics, Inc. | -87.63 Million USD | -97.851% |
ClearPoint Neuro, Inc. | -22.44 Million USD | -672.498% |
Integra LifeSciences Holdings Corporation | 111.52 Million USD | 255.475% |
Axonics, Inc. | -26.05 Million USD | -565.445% |
Outset Medical, Inc. | -169.77 Million USD | -2.135% |
IRIDEX Corporation | -10 Million USD | -1632.737% |
PROCEPT BioRobotics Corporation | -109.17 Million USD | -58.83% |
IRadimed Corporation | 20.03 Million USD | 965.441% |
Tivic Health Systems, Inc. | -8.24 Million USD | -2003.032% |
INVO Bioscience, Inc. | -6.76 Million USD | -2462.303% |
Telesis Bio, Inc. | -35.15 Million USD | -393.3% |
Viemed Healthcare, Inc. | 14.33 Million USD | 1310.014% |
Varex Imaging Corporation | 32.1 Million USD | 640.171% |
Quipt Home Medical Corp. | 3.91 Million USD | 4524.471% |
Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1329.119% |
Pulmonx Corporation | -61.93 Million USD | -179.963% |
Dynatronics Corporation | -2.27 Million USD | -7528.303% |
Modular Medical, Inc. | -17.52 Million USD | -889.189% |
ReShape Lifesciences Inc. | -14.63 Million USD | -1084.473% |
Semler Scientific, Inc. | 22.25 Million USD | 879.093% |
InMode Ltd. | 195.66 Million USD | 188.621% |
Bruker Corporation | 436.9 Million USD | 139.688% |
Cytosorbents Corporation | -31.2 Million USD | -455.588% |
DexCom, Inc. | 597.7 Million USD | 129.01% |
Align Technology, Inc. | 643.33 Million USD | 126.952% |
Viveve Medical, Inc. | -21.55 Million USD | -704.505% |
ZimVie Inc. | -30.93 Million USD | -460.442% |
Movano Inc. | -29.69 Million USD | -484.018% |
Cytek Biosciences, Inc. | -27.84 Million USD | -522.715% |
Nexalin Technology, Inc. | -5.69 Million USD | -2943.996% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -4814.824% |
Tandem Diabetes Care, Inc. | -233.23 Million USD | 25.655% |
Profound Medical Corp. | -28.61 Million USD | -505.937% |
Insulet Corporation | 220 Million USD | 178.816% |
enVVeno Medical Corporation | -25.23 Million USD | -587.039% |
Surmodics, Inc. | -5.64 Million USD | -2971.656% |
iCAD, Inc. | -7.68 Million USD | -2155.105% |
Nuwellis, Inc. | -17.63 Million USD | -883.522% |
Biotricity, Inc. | -8.82 Million USD | -1864.088% |
iRhythm Technologies, Inc. | -125.16 Million USD | -38.538% |
Aethlon Medical, Inc. | -12.63 Million USD | -1272.168% |
InspireMD, Inc. | -21.14 Million USD | -720.106% |
PAVmed Inc. | -68.79 Million USD | -152.046% |
BIOLASE, Inc. | -17.93 Million USD | -866.689% |
Beyond Air, Inc. | -63 Million USD | -175.204% |
FONAR Corporation | 16.53 Million USD | 1148.631% |
AxoGen, Inc. | -21.46 Million USD | -707.916% |
Vivani Medical, Inc. | -26.96 Million USD | -543.037% |
Tactile Systems Technology, Inc. | 18.04 Million USD | 1061.116% |
Inari Medical, Inc. | -14.03 Million USD | -1135.711% |
UFP Technologies, Inc. | 57.66 Million USD | 400.699% |
QT Imaging Holdings, Inc. | -4.92 Million USD | -3418.853% |
Heart Test Laboratories, Inc. | -6.3 Million USD | -2649.783% |
Tenon Medical, Inc. | -15.72 Million USD | -1002.531% |
Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -2219.976% |
Co-Diagnostics, Inc. | -42.7 Million USD | -306.018% |
AdaptHealth Corp. | -598.4 Million USD | 71.024% |
Sintx Technologies, Inc. | -13.35 Million USD | -1198.061% |
NanoVibronix, Inc. | -3.43 Million USD | -4946.42% |
Quanterix Corporation | -49.7 Million USD | -248.876% |
Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1329.119% |
Sensus Healthcare, Inc. | -382 Thousand USD | -45291.361% |
Pacific Biosciences of California, Inc. | -334.46 Million USD | 48.158% |
TransMedics Group, Inc. | -28.72 Million USD | -503.596% |
ReWalk Robotics Ltd. | -23.61 Million USD | -634.351% |
NeuroMetrix, Inc. | -7.15 Million USD | -2324.589% |
Hyperfine, Inc. | -48.11 Million USD | -260.376% |
Establishment Labs Holdings Inc. | -65.02 Million USD | -166.655% |
Biomerica, Inc. | -6.36 Million USD | -2623.339% |
Bone Biologics Corporation | -9.42 Million USD | -1739.09% |
AVITA Medical, Inc. | -40.4 Million USD | -329.173% |
Bluejay Diagnostics, Inc. | -10.31 Million USD | -1581.615% |
Silk Road Medical, Inc | -59.27 Million USD | -192.546% |